GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the Australia rule is doing its job and people should stop complaining — 27 comments in the full submission. View in context.
186
c/glp1aus·submitted 1 year ago by u/kian_solberg

[Meta] the Australia rule is doing its job and people should stop complaining

TGAbranch of 7 comments

the Australia rule is doing its job and people should stop complaining. Short post, long comment section, probably. The compounded arrangements changed while I was mid-thread and I was arguing from a superseded position. The two decisions that this whole board turns on, kept apart. Registration means a product may…

Read the full submission and all 27 comments →

This branch

7 comments, started 1 year ago
u/nz_unfundedMOD17 points·1 year ago

Flagged as describing the superseded compounded arrangements — left up with a note rather than removed.

replysharereportpermalink
u/kenji_kimani13 points·1 year ago

Cosigning on asking the pharmacy to check the wholesaler. It converts speculation into a fact in one phone call.

replysharereportpermalink
u/controversial_only14 points·1 year ago

Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.

replysharereportpermalink
u/tomas_broberg3 points·1 year ago

Read the published criteria for my indication rather than asking. Twenty minutes, and it answered everything I had been guessing at.

replysharereportpermalink
u/chain_confirm_cpayments4 points·1 year ago

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

replysharereportpermalink
u/fatima_yildiz3 points·1 year ago

What did the pharmacy quote for the private price?

replysharereportpermalink
u/kavya_kravchenko9 points·1 year ago

Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.

replysharereportpermalink

← back to the whole thread

About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.